We are live on ! Find out more
ARTX

Arotech
ARTX

Delisted

ARTX was delisted on the 18th of December, 2019.

30 hedge funds and large institutions have $6.44M invested in Arotech in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 29 → 30 (+1)

0.33% less ownership

Funds ownership: 10.34% → 10.01% (-0.33%)

28% less capital inflows, than outflows

Capital inflows: $484K | Capital outflows: $669K

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
30
Holders Change
+1
Holders Change %
+3.45%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
8
Closed
5
Calls
$134K
Puts
–
Net Calls
+$134K
Net Calls Change
+$216K

ARTX Hedge Fund Activity: Q1 2016 in Review

30 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Arotech (ARTX) for Q1 2016, worth a combined $6.44M — up 15% from $5.58M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ARTX positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $180K. The largest seller was Connective Capital Management, cutting an estimated $338K.

  • 30 institutional investors held Arotech (ARTX) as of Q1 2016, up from 29 in Q4 2015.
  • Funds reported $6.44M of Arotech stock for Q1 2016, up 15% quarter-over-quarter.
  • 6 funds opened new Arotech positions in Q1 2016 and 5 closed out, a net change of +1 holder.
  • The largest Arotech buyer in Q1 2016 was Vanguard Group, an estimated $180K added.
  • The largest Arotech seller in Q1 2016 was Connective Capital Management, an estimated $338K sold.

Based on aggregated 13F filings for Q1 2016.